SOHO Highlights: State of the Art and Next Questions
K

R/R PTCL State of the Art: Allo-SCT vs. Auto-SCT? Can Pralatrexate Change the Tumor Volume? Does Duvelisib+Romidepsin Increase ORR?

By SOHO Highlights: State of the Art and Next Questions FEATURING Kerry Savage
By SOHO Highlights: State of the Art and Next Questions FEATURING Kerry Savage
16 views
February 3, 2021
0 Comments
Login to view comments. Click here to Login

Featured Video

13:04
Winship Cancer Institute - Emory University

Treatment-Related Quality of Life in MF

Feat. A. Hunter

Featured Video

15:14
Icahn School of Medicine at Mount Sinai

Safety Profile of Ruxolitinib in Patients With MF

Feat. D. Tremblay

Related Content

AUTOPLAY
23:03
MyCancerHaven

Basics of T-Cell Lymphoma: Diagnosis and Treatment

Feat. R. Vij, N. Mehta-Shah
55:12
University of Colorado Division of Hematology

A Personalized Approach for T-Cell Lymphomas

Feat. B. Haverkos
19:38
19th Annual International Ultmann Chicago Lymphoma Symposium

T-Cell Lymphomas: Impact of Classification on Treatment

Feat. N. Mehta-Shah
21:53
Penn Medicine's 2023 Updates in Care of the Hematologic Malignancies Patient

Therapeutic Advances in T-Cell Lymphomas

Feat. S. Barta
11:01
i3 Health

Diagnosis and Evidence-Based Management of T-Cell Lymphoma

Feat. A. Goodman
34:28
Indy Hematology Review

Advancing Therapeutic Outcomes in Aggressive B and T Cell Lymphomas

Feat. T. Phillips
10:50
SOHO 2023 Eleventh Annual Meeting

SOHO 2023 Next Questions: T-Cell Lymphoma

Feat. M. Lunning
18:10
SOHO Brazil 2023

2023 SOHO® Brazil: "Moving Beyond CHOP/CHOEP - How Disease Feat…

Feat. A. Moskowitz
19:32
SOHO 2023 Eleventh Annual Meeting

SOHO 2023: Tailoring Therapy for PTCL

Feat. J. Zain
16:27
Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient

Therapeutic Advances in T-Cell Lymphoma in 2024

Feat. S. Barta
18:39
SOHO 2023 Eleventh Annual Meeting

SOHO 2023: Managing Rare T-Cell Lymphoma Subtypes

Feat. B. Pro
11:27
Penn Medicine Abramson Cancer Center

EHA and ASCO 2022 Penn Medicine Updates on Targeted Therapies and Im…

Feat. S. Barta
10:33
SOHO 2023 Eleventh Annual Meeting

SOHO 2023: A Multidisciplinary Approach to the Management of Mycosis…

Feat. C. Querfeld
12:55
Yale Cancer Center

ASH 2022 Highlights: T-Cell Lymphoma and Hodgkin Lymphoma

Feat. T. Sethi
18:54
SOHO 2023 Eleventh Annual Meeting

SOHO 2023: New Insights Into the Pathogenesis of T-Cell Lymphoma and…

Feat. L. de Leval
38:56
SOHO Highlights: State of the Art and Next Questions

State of the Art and Next Questions: T-Cell Lymphoma

Feat. M. Lunning
41:01
University of Colorado Division of Hematology

Recent Updates in Lymphoma: PD-1 mAbs and Novel Cell Therapy in cHL …

Feat. B. Haverkos
17:35
RWJBarnabas Health Rutgers Cancer Institute of New Jersey

Lymphoma During Pregnancy

Feat. A. Evens
16:35
SOHO 2022 Tenth Annual Meeting

SOHO 2022: Integrating Novel Agents Into the Management of Cutaneous…

Feat. P. Allen
41:39
19th Annual International Ultmann Chicago Lymphoma Symposium

Venous Thromboembolism in Lymphoma: Risk Stratification, Prophylaxis…

Feat. K. Cohen